2010 - Grand Prix scientifique de la Fondation NRJ, Institut de France
The scientist’s investigation covers issues in Dementia, Alzheimer's disease, Disease, Neuroscience and Psychiatry. Bruno Dubois combines subjects such as Clinical trial, Pediatrics and Neuropsychology with his study of Dementia. His studies deal with areas such as Cognitive decline, Audiology and Degenerative disease as well as Alzheimer's disease.
His Disease research also works with subjects such as
Bruno Dubois focuses on Disease, Dementia, Neuroscience, Internal medicine and Cognition. The study incorporates disciplines such as Biomarker, Clinical trial, Neuroimaging and Intensive care medicine in addition to Disease. Degenerative disease is closely connected to Alzheimer's disease in his research, which is encompassed under the umbrella topic of Dementia.
His work on Parkinson's disease expands to the thematically related Neuroscience. He has researched Internal medicine in several fields, including Placebo, Endocrinology, Oncology and Cardiology. His Cognition study combines topics from a wide range of disciplines, such as Developmental psychology, Cognitive psychology and Audiology.
His scientific interests lie mostly in Disease, Internal medicine, Dementia, Cohort and Oncology. His study in Disease is interdisciplinary in nature, drawing from both Biomarker, Asymptomatic and Neuroimaging, Neuroscience. His research in Internal medicine intersects with topics in Endocrinology and Allele.
The Dementia study combines topics in areas such as Alzheimer's disease and Cognitive impairment. He works mostly in the field of Cohort, limiting it down to topics relating to Cognition and, in certain cases, Neurology, as a part of the same area of interest. Bruno Dubois has included themes like Precision medicine, Receiver operating characteristic and Amyloidosis in his Oncology study.
Bruno Dubois mainly focuses on Disease, Cohort, Dementia, Internal medicine and Biomarker. His work deals with themes such as Incidence, Gerontology, Cognition, Neuroscience and Intensive care medicine, which intersect with Disease. The concepts of his Neuroscience study are interwoven with issues in Progressive supranuclear palsy, Neuropathology and Set.
He frequently studies issues relating to Alzheimer's disease and Dementia. His Internal medicine study integrates concerns from other disciplines, such as Positron emission tomography and Oncology. His research integrates issues of Immunology, Immune system, Immunity, Parkinson's disease and Cellular pathology in his study of Biomarker.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium
I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre.
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Bruno Dubois;Howard H. Feldman;Claudia Jacova;Steven T. DeKosky.
Lancet Neurology (2007)
The FAB A frontal assessment battery at bedside
B. Dubois;A. Slachevsky;I. Litvan;B. Pillon.
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins.
Movement Disorders (2008)
The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease
Marilyn S. Albert;Steven T. DeKosky;Dennis Dickson;Bruno Dubois.
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) Report of the NINDS-SPSP International Workshop*
I. Litvan;Y. Agid;D. Calne;G. Campbell.
Clinical diagnostic criteria for dementia associated with Parkinson's disease.
Murat Emre;Dag Aarsland;Dag Aarsland;Richard Brown;David J. Burn.
Movement Disorders (2007)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma;Daniela Berg;Matthew Stern;Werner Poewe.
Movement Disorders (2015)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)
Revising the definition of Alzheimer's disease: a new lexicon.
Bruno Dubois;Howard H. Feldman;Howard H. Feldman;Howard H. Feldman;Claudia Jacova;Jeffrey L. Cummings.
Lancet Neurology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: